Regeneron Reports First Quarter 2013 Financial and Operating Results
Regeneron Reports First Quarter 2013 Financial and Operating Results Regeneron and Bayer HealthCare are conducting Phase 3 trials, VISTA-DME and VIVID-DME, to evaluate the efficacy and safety of EYLEA...
View ArticleRegeneron Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual …
Regeneron Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual … And despite deficiencies that were identified, they continued to supply these drugs, and it resulted in really one of the largest...
View Article
More Pages to Explore .....
